Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00042848 · ClinicalTrials.gov registry record · Phase 3
Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer
A Phase 3 study, sponsored by Gary Morrow.
- Completed
- Registry status
- Phase 3
- Development phase
- 837
- Enrollment target
NCT00042848 is a Phase 3 study that has completed, run by Gary Morrow. The registered enrollment target is 837 participants.
The verdict
NCT00042848, a Phase 3 study, has completed, sponsored by Gary Morrow.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 837 participants
- Enrollment target
Study Summary
RATIONALE: Modafinil may be effective in relieving fatigue in patients with cancer who are undergoing chemotherapy. The effectiveness of modafinil in relieving chemotherapy-related fatigue is not yet known. PURPOSE: This randomized phase III trial is studying the effectiveness of modafinil in treating fatigue in patients who are receiving chemotherapy for cancer.
Interventions
- DRUG modafinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 837 participants |
| Start Date | 2002-08 |
| Est. Completion | 2007-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00042848
The ClinicalTrials.gov registry entry for NCT00042848 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 837 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gary Morrow, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which modafinil is the first listed.
NCT00042848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00042848 about?
NCT00042848 is a clinical study titled "Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer". RATIONALE: Modafinil may be effective in relieving fatigue in patients with cancer who are undergoing chemotherapy. The effectiveness of modafinil in relieving chemotherapy-related fatigue is not yet known. PURPOSE: This randomized phase III trial is studying the effectiveness of modafinil in treat...
What is the current status of trial NCT00042848?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 837 participants. The study started on 2002-08. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00042848?
The interventions under investigation include: modafinil (DRUG).
Who is sponsoring clinical trial NCT00042848?
This trial is sponsored by Gary Morrow, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.